Clinical trials in Barcelona – page 39

3 147 clinical trials in Barcelona, Spain across 23 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Barcelona at a glance

3 147

clinical trials

Research sites23

Quick filters

3 147 trials in Barcelona

Open in trial search

Adenocarcinoma gastric+2

Recruiting

A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

Registered drugNo placebo

A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tislelizumab
Sponsor:BeOne Medicines AG

Contact Research Centre

Squamous cell carcinoma of head and neck+1

Recruiting

Testing the Safety and Effects of TUB-030 in Patients with Advanced Head and Neck Cancer or Non-Small-Cell Lung Cancer

InvestigationalNo placebo

Testing the Safety and Effects of TUB-030 in Patients with Advanced Head and Neck Cancer or Non-Small-Cell Lung Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:TUB-030
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Germ cell cancer

Recruiting

Study of Autologous Tumor-Infiltrating Lymphocytes with Cyclophosphamide, Fludarabine and Aldesleukin in Patients with Germ Cell Tumors

Registered drugNo placebo

Study of Autologous Tumor-Infiltrating Lymphocytes with Cyclophosphamide, Fludarabine and Aldesleukin in Patients with Germ Cell Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL

Contact Research Centre

Gastrooesophageal cancer+1

Recruiting

A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

Registered drugNo placebo

A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:FRUQUINTINIB
Sponsor:Fondation Franc.Cancerologie Digestive

Contact Research Centre

Neoplasm

Recruiting

A Study of BMS-986517 for Adults with Advanced Solid Tumors to Test Safety and Find the Best Dose

InvestigationalNo placebo

A Study of BMS-986517 for Adults with Advanced Solid Tumors to Test Safety and Find the Best Dose

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Breast cancer+2

Recruiting

A Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy

InvestigationalNo placebo

A Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Datopotamab Deruxtecan
Sponsor:AstraZeneca AB

Contact Research Centre

Prostate cancer

Recruiting

A Study of GSK5458514 Alone or With Other Cancer Drugs in Adults With Metastatic Castration-Resistant Prostate Cancer

InvestigationalNo placebo

A Study of GSK5458514 Alone or With Other Cancer Drugs in Adults With Metastatic Castration-Resistant Prostate Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:GSK5458514
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Adenomatous polyposis coli

Recruiting

A study testing sirolimus to slow disease progression in patients with familial adenomatous polyposis

Investigational

A study testing sirolimus to slow disease progression in patients with familial adenomatous polyposis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Sirolimus
Sponsor:Biodexa Limited

Contact Research Centre

Infertility

Recruiting

Study of Semaglutide on Embryo Quality in Overweight and Obese Women Undergoing In Vitro Fertilization for Infertility

Registered drugNo placebo

Study of Semaglutide on Embryo Quality in Overweight and Obese Women Undergoing In Vitro Fertilization for Infertility

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Follitropin Alfa
Sponsor:Santiago Dexeus Font Fundacio Privada

Contact Research Centre

Osteoarthritis

Recruiting

A study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands

Investigational

A study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Montelukast
Sponsor:Farmalider S.A.

Contact Research Centre

Cardiomyopathy

Recruiting

Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

Registered drugNo placebo

Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Altizide
Sponsor:Andrea Di Marco

Contact Research Centre

Non-small cell lung cancer stage IV+2

Recruiting

A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment

Registered drug

A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Barcelona

What the registry says about research in the country

01 Neurodegenerative Research

Innovative studies focusing on Alzheimer's Disease and Frontotemporal Dementia, utilizing advanced brain imaging techniques to track disease progression and evaluate new therapeutic approaches.

Cerebral tau aggregates assessment
Amyloid deposition tracking
Progressive supranuclear palsy research

Advanced neuroimaging studies using PET tracers to understand disease mechanisms.

02 Infectious Disease Prevention

Comprehensive vaccine trials targeting various infections including Respiratory Syncytial Virus, Cytomegalovirus, and Herpes Zoster.

RSV vaccine development for older adults
CMV prevention studies
COVID-19 booster research

Focus on developing effective immunization strategies for vulnerable populations.

03 Metabolic and Chronic Conditions

Research examining treatments for Type 1 Diabetes and obesity, alongside studies in bladder cancer and urinary tract infections.

Diabetes management therapies
Cancer immunotherapy trials
UTI vaccine development

Innovative approaches to chronic disease management and prevention.

Back to Spain All countries